SB-742510 is a semi-synthetic pleuromutilin antibiotic that is being developed for treatment of respiratory infections. The purpose of this study is to estimate the bioavailability of four different formulations and to evaluate the safety of each of the four formulations
Study Type
OBSERVATIONAL
Enrollment
32
GSK Investigational Site
Tacoma, Washington, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.